Scientists from a European Consortium reconstructed a global Mycobacterium chimaera outbreak by whole genome sequencing. The report has identified contaminated heater-cooler units as the likely source
DZIF researchers at the Helmholtz Centre for Infection Research (HZI) develop new agents and methods for the localisation and treatment of multi-resistant bacteria. Molecular probes utilise the iron
The German Center for Infection Research (DZIF) and the University of Tübingen and its University Hospitals have joined with international partners to contribute to the founding of a new school for
Some HIV-infected – and untreated children – who do not develop AIDS, control the virus in a different way from the few infected adults who remain disease-free. Dr Maximilian Muenchhoff, DZIF
Prof Marcus Altfeld and Dr Angelique Hölzemer from the Heinrich Pette Institute (HPI) have been honoured with the "Hector Award HIV 2017”. Both scientists also work at the DZIF research field HIV.
The European Medicines Agency (EMA) has granted “PRIME eligibility” to Myrcludex B, and will provide priority support for its further drug development. The hepatitis B and D virus entry inhibitor was
Dr Vytenis Andriukaitis, EU Commissioner for Health and Food Safety, visited the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) to inform himself about multidrug-resistant pathogens
Researchers at the ImmunoSensation cluster of excellence at the University of Bonn have managed to do what many scientists dream of: together with researchers from the USA, they have patented new
The DZIF Academy is pleased to open the call for application for the fourth DZIF Prize for Translational Infection Research. The German Center for Infection Research (DZIF) will award a prize of 5.000
In 2016, a clinical phase I trial on a potential vaccine against the dreaded Ebola virus was successfully completed. The tested vaccine “rVSV-ZEBOV” proved to be safe and effective. In a further trial
